DBV Technologies | Beban Penjualan Dan Administrasi





Beban Penjualan Dan Administrasi Perubahan Tanggal
Acadia Pharmaceuticals USD 124.9M 1.24M 2025-09
Alnylam Pharmaceuticals USD 262.59M 60.72M 2025-09
Amarin USD 17.94M 17.86M 2025-09
BioCryst Pharmaceuticals USD 80.47M 15.39M 2024-12
BioMarin Pharmaceutical USD 223.42M 8.86M 2025-09
DBV Technologies USD 3.63M 3.18M 2025-09
Esperion Therapeutics USD 39.98M 4.21M 2024-09
Galectin Therapeutics USD 1.48M 110K 2024-06
Halozyme Therapeutics USD 37.53M 4.53M 2025-09
Incyte USD 390.41M 61.33M 2025-12
Insmed USD 186.38M 109.94M 2025-09
Ionis Pharmaceuticals USD 86.56M 4.04M 2025-09
Neurocrine Biosciences USD 301.8M 10.2M 2025-12
PTC Therapeutics USD 84.05M 1.22M 2025-09
Sarepta Therapeutics USD 77.11M 7.22M 2025-09
Ultragenyx Pharmaceutical USD 86.62M 26K 2025-09
United Therapeutics USD 152M 60.5M 2025-09


DBV Technologies Beban Penjualan Dan Administrasi - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Feb 2026.